Superior HealthPlan Encourages Effort to Stop Prescription Drug Misuse
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/27/2026
- Nasdaq futures outperform after Nvidia puts AI fears to rest
- Nvidia forecasts 70% sales growth next year, signals AI spending boom has years left to run
- Oil gains as traders weigh prospects of easing Middle East supply disruptions
- Could SpaceX's orbital compute avoid the political headwinds facing data centers?
- Dollar General stock jumps on earnings beat and raised guidance
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
- Boston Scientific discloses cybersecurity incident causing global disruption
- Crude Inventory Rose 0.1 Million Barrels Last Week - EIA
- Wall Street stocks end tad lower after hot inflation data ahead of Nvidia earnings
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Centene (CNC) PT Raised to $85 at Jefferies; Reiterates Buy
April 26, 2017 9:21 AM EDTJefferies raised its price target on Centene (NYSE: CNC) to $85.00 (from $83.00) while maintaining a Buy rating. CNC reported 1Q EPS of $1.12, 8% ahead of consensus estimates. Higher revenue and lower MLR more than offset higher SG&A.
Analyst David Windley remains... More
